Bone marrow failure and leukemia predisposition syndromes

Date: November 15-17, 2024
Location: Paris, France
Format: In-person

Myeloproliferative disorders

Date: November 14-15, 2024
Location: Varna, Bulgaria
Format: Hybrid

EHA's pilot preceptorship on Sickle Cell Disease.

Dates: October 16-18, 2024
Location: Paris, France
Format: In-person

New aspects in diagnostic choices and treatment options of hematological malignancies

Date: October 18-20, 2024
Location: Tbilisi, Georgia
Format: In-person

Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT)

Date: October 2-5, 2024
Location: London, United Kingdom

Bridging between functional and genomic precision medicine

Date: September 25-27, 2024
Location: Copenhagen, Denmark
Format: In-person

Recent advances in lymphoid and myeloid malignancies

Date: September 14-15, 2024
Location: Almaty, Kazakhstan
Format: In-person

T Cell Lymphomas

Date: June 29-30, 2024
Location: Ankara, Türkiye
Format: In-person

The EHA2024 Hybrid Congress is a chance for the you to reconnect and exchange knowledge with the global hematology community in person and online.

Date: May 14, 2024, 18:00-19:00 (CEST)
Format: Virtual

The role of BMT in the treatment of malignant hemopathy in 2024

Date: April 19, 2024
Location: Tirana, Albania
Format: Hybrid

Hodgkin Lymphoma

Date: April 17-18, 2024
Location: Kuala Lumpur, Malaysia
Format: In-person

11th EHA Pediatric Hemato-Oncology Course

Date: April 10-13, 2024
Location: Sorrento, Italy

Treatment and management of SCD

Date: March 22, 2024
Format: Webinar

EHA Research Conference 2024

"Molecular vulnerabilities and metabolism in hematological disorders"

Date: March 18-21, 2024
Location: Borovets, Bulgaria
Format: In-person

6th EHA-EBMT European CAR T-cell Meeting

Date: February 15-17, 2024
Location: Valencia, Spain
Format: Hybrid

On-demand content available until March 17, 2024.